Smartphone program aims to help HIV patients kick the habit
NCT ID NCT05014282
First seen Nov 14, 2025 · Last updated Jun 23, 2026 · Updated 35 times
Summary
This study tests whether a smartphone-based program can help people living with HIV quit smoking better than standard phone counseling. About 638 participants will use nicotine patches and lozenges along with either automated video coaching or traditional quitline support. The goal is to see which approach leads to more people staying smoke-free long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMOKING CESSATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Nicotine patch and nicotine lozenge
What this could lead to
If successful, this could provide an effective, low-cost way to help people with HIV quit smoking, reducing their risk of smoking-related diseases.
What could go wrong
This is a behavioral intervention trial, not a new drug. Success depends on participants' adherence, and results may not apply to all smokers with HIV.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.